{"database": "openregs", "table": "documents", "rows": [["FDA-1975-N-0012-0479", "FDA", "FDA-1975-N-0012", "FDA CDER Letter to Manufactures for OTC Topical Antiseptic Drug Products Request Labeling Changes re Dukal Corporation\nProlongacion Canal de Miramontes Dukal Corporation Del Mun Tlalpan CP 14387 Mexico", "Other", "Letter(s)", "2014-03-16T04:00:00Z", 2014, 3, "2014-03-16T04:00:00Z", null, "2014-03-16T15:13:46Z", null, 0, 0, "09000064814b006e"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1975-N-0012-0479"], "units": {}, "query_ms": 0.4138130461797118, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}